Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000794661 | SCV000934082 | uncertain significance | Cohen syndrome | 2021-08-28 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000794661 | SCV002079545 | uncertain significance | Cohen syndrome | 2020-12-10 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004742638 | SCV005344218 | uncertain significance | VPS13B-related disorder | 2024-01-02 | no assertion criteria provided | clinical testing | The VPS13B c.2993T>G variant is predicted to result in the amino acid substitution p.Val998Gly. To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |